Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0468 | 1 | 1 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0468 | 1 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.0468 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0468 | 1 | 1 |
Toxoplasma gondii | EGF family domain-containing protein | 0.0151 | 0 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0468 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0468 | 1 | 1 |
Brugia malayi | Peroxidasin | 0.0468 | 1 | 1 |
Brugia malayi | Blistered cuticle protein 3 | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Onchocerca volvulus | Dual oxidase homolog | 0.0468 | 1 | 1 |
Echinococcus multilocularis | peroxidasin | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Giardia lamblia | High cysteine protein | 0.0151 | 0 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0468 | 1 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0468 | 1 | 1 |
Onchocerca volvulus | 0.0468 | 1 | 1 | |
Schistosoma mansoni | peroxidasin | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0468 | 1 | 1 |
Schistosoma mansoni | peroxidasin | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Echinococcus granulosus | peroxidasin | 0.0468 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0468 | 1 | 1 |
Onchocerca volvulus | 0.0468 | 1 | 1 | |
Onchocerca volvulus | 0.0468 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Concentration (functional) | = 11 uM | Concentration of the compound required to double the thrombin time in human plasma (TT) | ChEMBL. | 12617892 |
Concentration (functional) | = 42.3 uM | Concentration of the compound required to double the activated partial thromboplastin time in human plasma (APTT) | ChEMBL. | 12617892 |
Concentration (functional) | = 78.3 uM | Concentration of the compound required to double the activated prothrombin time in human plasma (PT) | ChEMBL. | 12617892 |
Ki (binding) | = 0.14 uM | In vitro inhibitory activity against Thrombin | ChEMBL. | 12617892 |
Ki (binding) | = 0.14 uM | In vitro inhibitory activity against Thrombin | ChEMBL. | 12617892 |
Ki (binding) | > 68.3 uM | In vitro inhibitory activity against Trypsin | ChEMBL. | 12617892 |
Ki (binding) | > 68.3 uM | In vitro inhibitory activity against Trypsin | ChEMBL. | 12617892 |
Ki (binding) | > 75.4 uM | In vitro inhibitory activity of the compound against Factor Xa | ChEMBL. | 12617892 |
Ki (binding) | > 75.4 uM | In vitro inhibitory activity of the compound against Factor Xa | ChEMBL. | 12617892 |
Ratio (binding) | > 478 | Selectivity ratio of thrombin to trypsin | ChEMBL. | 12617892 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.